08:00 , Mar 25, 2002 |  BioCentury  |  Strategy

Alkermes buys into specialty pharma

Alkermes Inc. 's acquisition of Reliant Pharmaceuticals LLC checks two boxes in ALKS's bid to become a big cap specialty pharmaceutical company. The deal puts ALKS within spitting distance of the top tier of biotech...
08:00 , Mar 25, 2002 |  BioCentury  |  Strategy

Selected products from the combined pipeline of Alkermes and Reliant

Selected products from the combined pipeline of Alkermes and Reliant...
08:00 , Dec 24, 2001 |  BioCentury  |  Strategy

Investing in the sales channel

A major reason biotech companies partner with pharma is to obtain access to large sales organizations that can address primary care and other broad markets. Alkermes Inc. may have found a different entrée to such...
07:00 , Jul 27, 1998 |  BioCentury  |  Strategy

Heartburn remedies

Heartburn remedies...